An Overview of the Safety, Efficiency, and Signal Pathways of Stem Cell Therapy for Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple organs and tissues. Mesenchymal stem cells (MSCs) are considered a good source for autoimmune disease and hematological disease therapy. This review will summarize the efficacy, safety, and mechanisms of MSC therapy fo...
Saved in:
Main Authors: | Qian Yang, Yiping Liu, Guangyong Chen, Wancong Zhang, Shijie Tang, Tianbiao Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2021/2168595 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Programmed Cell Death Pathways in the Pathogenesis of Systemic Lupus Erythematosus
by: Fangyuan Yang, et al.
Published: (2019-01-01) -
Systemic Lupus Erythematosus
by: Chaim Putterman, et al.
Published: (2012-01-01) -
Costimulatory Pathways: Physiology and Potential Therapeutic Manipulation in Systemic Lupus Erythematosus
by: Nien Yee Kow, et al.
Published: (2013-01-01) -
Lupus Enteritis as an Initial Presentation of Systemic Lupus Erythematosus
by: Sisira Sran, et al.
Published: (2014-01-01) -
Early Postoperative Safety of Total Hip Arthroplasty in Systemic Lupus Erythematosus Patients
by: YANG Xingdong, et al.
Published: (2025-01-01)